retractable.com (RVP): Rasio rega marang prakiraan pendapatan
The growth of government orders for safety syringes and exports to emerging markets define the financial profile of Retractable Technologies (RVP). The forward P/S ratio visualizes market expectations, where 0.50 shapes the current metric. Capital optimization is based on strategic alliances with the US government, while the stability of the B2B ecosystem and strict regulatory standards guarantee the retention of the hospital client base.
Rincian analitis perusahaan retractable.com (RVP)
- rega saham lan target rega konsensus:
- data kapitalisasi bursa:
- indikator nilai buku ekuitas:
- data tingkat utang lan likuiditas finansial:
Rasio Total Utang marang Ekuitas Retractable Technologies|RVP - Rasio silihan jangka dawa marang modal|Utang jangka cendhak marang ekuitas Retractable Technologies, Inc.|RVP - Gunggung kewajiban utang perusahaan|Rasio utang marang kapitalisasi buku Retractable Technologies, Inc.|RVP - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Retractable Technologies|Indikator likuiditas cepet retractable.com
- rincian asil keuangan lan kelipatan valuasi:
RVP - Bathi sawise mbayar pajeg|Bathi sing dikarepake Retractable Technologies|RVP - Nilai perusahaan marang bathi resik|Pangali Forward P/E Retractable Technologies, Inc.|RVP - Pangali PEG|Pangali EV/EBITDA Retractable Technologies, Inc.|RVP - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Retractable Technologies|RVP - Bathi saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan retractable.com|RVP - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Retractable Technologies
- rincian pendapatan lan dodolan:
Analisis komprehensif perusahaan:RVP (Retractable Tech)
This indicator compares current market capitalization with expected annual revenue, allowing investors to track the dynamics of market expectations and the risk of asset overvaluation. By analyzing the forward P/S ratio, one can assess the extent to which the market currently prices in the successful scaling of robotic lines and the implementation of AI control in the production of medical instruments by Retractable Technologies (RVP).
Pesaing wigati
Intuitive - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S Danaher Corporation DHR|BDX - Rasio rega marang prakiraan pendapatan|STERIS Group (STE) - Multiplikator forward rega marang pendapatan|WST: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep baxter.com (BAX)|Rasio rega marang prakiraan pendapatan Masimo|Kapitalisasi marang prakiraan pendapatan STVN (Stevanato Group SpA)|Multiplikator forward rega marang pendapatan TFX (Teleflex Inc)|Rasio rega marang pendapatan sing dikarepake MMSI|Rasio rega marang prakiraan pendapatan Envista Holdings NVST|Rasio kapitalisasi marang dodolan sing dikarepake icumed.com (ICUI)|XRAY - Rasio rega marang prakiraan pendapatan|Rega forward marang dodolan LMAT (LeMaitre Vascular Inc)|ATRC: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep STAAR Surgical Co (STAA)|Multiplikator forward rega marang pendapatan NAGE|ZIMV (zimvie.com) - Rasio rega marang pendapatan sing dikarepake|Rasio rega marang prakiraan pendapatan AngioDynamics (ANGO)|CERS (Cerus Corp.) - Rega forward marang dodolan|Multiplikator Forward P/S TKNO (Alpha Teknova Inc)|Multiplikator Forward P/S Monogram Orthopedics Inc. MGRM|Sharps Tech - Multiplikator Forward P/S|InfuSystem Holdings (INFU) - Multiplikator forward rega marang pendapatan|UTMD (Utah Medical Products, Inc.) - Multiplikator forward rega marang pendapatan|KRMD: Rasio rega marang pendapatan sing dikarepake|NYXH (Nyxoah, S.A.) - Multiplikator Forward P/S|Multiplikator Forward P/S Microbot Medical, Inc|Multiplikator Forward P/S PDEX|Rasio rega marang prakiraan pendapatan ZTEK (zentek.com)|Rasio rega marang prakiraan pendapatan Elutia ELUT|Milestone Scientific Inc - Rasio rega marang prakiraan pendapatan|NEXGEL, Inc - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep harvardbioscience.com|FEMY (Femasys Inc.) - Multiplikator forward rega marang pendapatan|Meihua Medical Technologies Co., Ltd. - Rega forward marang dodolan|Multiplikator forward rega marang pendapatan POAI|CJMB (Callan JMB Corp) - Rasio rega marang pendapatan sing dikarepake|Multiplikator Forward P/S ATRI|NURO - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep
